Please login to the form below

Not currently logged in

NHSA awarded £2.9m to boost life and health sciences

Funding will support operations in the north of England for five years

BMS signs $975m deal for Bavarian Nordic cancer vaccine

Bristol-Myers Squibb (BMS) buildingFurthers prominent position in immuno-oncology with Prostvac

German drug cost containment system 'aids data transparency'

New study by IQWiG suggests similar rules should be rolled out across Europe

Boehringer steals lead among NOACs with Pradaxa antidote

Has filed reversal agent for European approval

PMCPA 'appalled' by Chiesi's Code of Practice breach

pmcpa logoEthics watchdog says firm mislead it in a "completely unacceptable" manner

Patients should have a say in their medication, claims NICE

National Institute for Health and Care Excellence NICE logoAlso states health practitioners should be able to share information

New cancer meds and drug extensions top CHMP recommendations

EU flagDrugs for rare disease, oncology and diabetes top regulator’s endorsements

Gilead's Harvoni gains NICE yes - but won't face funding delay

gilead-harvoni-ledipasvir-sofosbuvirUnlike the company's Sovaldi, which won’t be paid for until the summer

J&J sells Cordis unit to Cardinal Health for $1.94bn

Johnson and Johnson logoMarks J&J’s exit from the cardiovascular stent market

darwins medicineDoes 'trust leadership' feature in your strategy?

Pharma companies wanting to be more patient-focused will need to develop their people skills

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Facilitate Ltd

Established in 2002, Facilitate is a global medical communications agency providing high-quality, creative services that focus on top-level opinion leader...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...